Log in to your Inderes Free account to see all free content on this page.
Inify Laboratories
Less than 1K followers
INIFY
Euronext Growth Oslo
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
Inify Laboratories provides cancer diagnostics through pathology laboratory services. The company uses a digital, standardized workflow for response times and quality assurance, initially within prostate diagnostics. The customers mainly consist of laboratories and hospitals. Inify Laboratories was founded in 2022 and has its headquarters in Stockholm.
Read moreMarket cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
30.4.
2025
Interim report Q1'25
20.5.
2025
General meeting '25
27.8.
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
Inify Laboratories AB: Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion
Inify Laboratories - New share capital registered
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio